USPTO serial 79430358
URIS
Reviewed by CopyMark Law Group
Status 645Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- KRUSSMAN, IAN GEORGE
- Law office
- TMO LAW OFFICE 126
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with URIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Electrodes and devices for neurostimulation for scientific and research purposes; Electrodes and devices for neuromodulation and electroceuticals treatment for scientific and research purposes; Downloadable and recorded computer software for use in the design and use of medical instruments and devices used in neuromodulation and electroceuticals treatment and therapy | ACTIVE | — |
| 010 | Medical apparatus and instruments used for neuromodulation and electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; Medical devices used for neuromodulation and electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; Electrodes for medical use used for neuromodulation and electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; Medical electrodes and medical devices for use in neuromodulation, electro-stimulation and electroceuticals treatment and therapy; Medical instruments and devices for use in electroceuticals and neuromodulation treatment and therapy; Medical devices, namely, pulse generators for neurostimulation | ACTIVE | — |
| 042 | Design, engineering, research, development and testing services for medical, scientific and technological products in the field of neuromodulation and electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; Design and development of medical instruments and devices for use in neuromodulation and electroceuticals treatment and therapy; Technology research in the field of medical instruments and devices for use in neuromodulation and electroceuticals treatment and therapy; Medical and scientific research services in the field of neuromodulation and electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; Medical and scientific research in the fields of urology, neurology, gynecology, infertility, overactive bladder, neurodegenerative diseases, and chronic diseases using neuromodulation and electroceuticals treatment and therapy; Providing medical and scientific research information in the fields of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; Research and development of technology in the field of healthcare and medical devices, namely, in the field of neuromodulation and electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; Development of technology in the field of medical instruments and devices for neuromodulation and electroceuticals treatment and therapy; Design and development of computer software; Software as a service (SAAS) services featuring software for use in the design and use of medical instruments and devices used in neuromodulation and electroceuticals treatment and therapy; Providing temporary use of on-line non-downloadable software for use in the design and use of medical instruments and devices used in neuromodulation and electroceuticals treatment and therapy | ACTIVE | — |
| 044 | Medical services in the field of neuromodulation and electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; Healthcare services in the nature of neuromodulation and electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; Medical services in the fields of urology, neurology, gynecology, infertility, neurodegenerative diseases, overactive bladder, and chronic diseases using electroceuticals and neuromodulation treatment and therapy; Medical consultancy; Providing medical information in the fields of urology, neurology, gynecology, infertility, neurodegenerative diseases, overactive bladder, and chronic diseases using electroceuticals and neuromodulation treatment and therapy; Medical treatment of low urinary tract disfunction, Parkinson's diseases, Alzheimer's diseases, bowel disfunction, epilepsy, migraine and infertility using electroceuticals and neuromodulation treatment and therapy; Rental of medical instruments and devices for use in electroceuticals and neuromodulation therapy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 15, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 15, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 15, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 14, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 14, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 14, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 26, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 6, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 6, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 6, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 5, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 31, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 30, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 30, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 12, 2025 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Aug 14, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |